Durable Regression of Primary Cutaneous B-Cell Lymphoma Following Fever-inducing Mistletoe Treatment: Two Case Reports. - Wikidata - wikimedia - TriplyDB

Durable Regression of Primary Cutaneous B-Cell Lymphoma Following Fever-inducing Mistletoe Treatment: Two Case Reports.

Durable Regression of Primary Cutaneous B-Cell Lymphoma Following Fever-inducing Mistletoe Treatment: Two Case Reports.

http://www.wikidata.org/entity/Q37323796

about

Fever: Views in Anthroposophic Medicine and Their Scientific Validity Mistletoe lectin has a shiga toxin-like structure and should be combined with other Toll-like receptor ligands in cancer therapy.High-Dose Viscum album Extract Treatment in the Prevention of Recurrent Bladder Cancer: A Retrospective Case Series Intravenous Mistletoe Treatment in Integrative Cancer Care: A Qualitative Study Exploring the Procedures, Concepts, and Observations of Expert Doctors.Anthroposophic medicine: an integrative medical system originating in europe.Coley's Lessons Remembered: Augmenting Mistletoe Therapy.Individualized Integrative Cancer Care in Anthroposophic Medicine: A Qualitative Study of the Concepts and Procedures of Expert Doctors.Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.Tumour response following high-dose intratumoural application of Viscum album on a patient with adenoid cystic carcinoma.Complete remission and long-term survival of a patient with melanoma metastases treated with high-dose fever-inducing Viscum album extract: A case report.Safety of Therapeutic Fever Induction in Cancer Patients Using Approved PAMP Drugs.

P2860

Q28072346-1BECC04C-36E6-4319-891B-B16CCD950C88 Q30351915-79AEDB07-246C-4686-BB86-4BE5D20E2C39 Q36224399-EA50F9D4-32BA-4DA6-8E09-213907C85496 Q36880805-9F648C91-4A29-4EEC-BA01-AA71CBDE9912 Q37397583-B4CCB4D1-748F-48D6-AE20-EA1530D2B5BE Q38840254-BE1DBA89-2706-4D03-9C2F-3165C4EBD6BB Q39790055-40D65452-5A46-4C66-94D0-96D68432FEB2 Q41634773-AC55F390-5DA6-46B9-991E-ACAF2F7BBC39 Q42265007-0860F7AB-CA31-49C5-ABD3-375DD5316C11 Q47277573-E11BAEF5-1E4A-4141-8E8D-E30B16E2A47A Q50095915-63893866-3E5A-44AD-ADCF-47EF00BCCBDA

P2860

Durable Regression of Primary Cutaneous B-Cell Lymphoma Following Fever-inducing Mistletoe Treatment: Two Case Reports.

http://www.wikidata.org/entity/Q37323796

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Durable Regression of Primary ...... e Treatment: Two Case Reports.

@en

Durable Regression of Primary ...... e Treatment: Two Case Reports.

@nl

type

label

Durable Regression of Primary ...... e Treatment: Two Case Reports.

@en

Durable Regression of Primary ...... e Treatment: Two Case Reports.

@nl

prefLabel

Durable Regression of Primary ...... e Treatment: Two Case Reports.

@en

Durable Regression of Primary ...... e Treatment: Two Case Reports.

@nl

P1433

Q37323796-CD2F57E8-92DF-478E-88F3-53347F18CA56

P1476

Q37323796-C74DAFD4-9D87-473F-B0DF-5530F285CB23

P2093

Q37323796-0B7DF7DE-A2A9-486E-BB6D-FABC3E10AE6A

Q37323796-18E8A765-E12A-4ACD-98D1-961DD706F1BB

Q37323796-3C02651B-4725-43C5-802C-BB6B000C0EEC

Q37323796-5DC913E7-A49A-48E4-BAE8-A20D4668AD08

Q37323796-8BF12363-7818-4735-A775-99DFC14DB3E0

Q37323796-F6CF459D-A52B-4183-8137-2115D3C3EBDF

P2860

Q37323796-00684CDA-9E6F-4847-BDF2-76FF3E43D0ED

Q37323796-01944435-03BD-466A-A16F-D92D24374FF2

Q37323796-0566B0A5-5BA7-4E64-AED3-4B387F8BDE51

Q37323796-0F8E3158-2163-430A-B296-9D49FE41AF13

Q37323796-10CE288E-7CD7-4683-AF4C-05F84D58BDEA

Q37323796-1AD1999A-C5B1-4409-AA6C-288C8911075A

Q37323796-3D2420F8-129F-4A0A-9D27-CC5615442714

Q37323796-3D710BA4-A566-40B5-B36F-6E8C55D0B27E

Q37323796-450C14B6-C196-4F70-BE2A-152F9B191ECB

Q37323796-4E3EE3AC-304C-4FB2-88FA-D84EB39626EB

P304

Q37323796-42CA4F82-02C6-4B09-97F2-3848F451E6C1

P31

Q37323796-244E3274-CFCA-402D-BA05-9904D8D425C9

Q37323796-9c8c8ca9-232d-4147-ad93-5ba3e51624ba

P356

Q37323796-AE4DA43A-F0B3-419E-A5E8-7CBC66BC03AF

P433

Q37323796-DEF6303C-D776-4396-A1C1-4D05AB0297B0

P478

Q37323796-75DB3792-DF07-4467-9B97-49DC9F6472E4

P577

Q37323796-E8DBA96D-96D4-4160-9FA1-08A1ED9AE0FE

P5875

Q37323796-D1E44116-370C-485D-B07D-AFF01E2822DB

P698

Q37323796-2091D6C4-C19C-4646-8806-B58B66F0B048

P932

Q37323796-184999DD-64DC-45EC-A107-941DBD4335E3

P356

GAHMJ.2012.1.1.006

P1433

Global advances in health and medicine: improving healthcare outcomes worldwide

P1476

Durable Regression of Primary ...... e Treatment: Two Case Reports.

@en

P2093

Aija Lace

http://www.w3.org/2001/XMLSchema#string

Broder H von Laue

http://www.w3.org/2001/XMLSchema#string

Gunver S Kienle

http://www.w3.org/2001/XMLSchema#string

Maria P Fonseca

http://www.w3.org/2001/XMLSchema#string

Maurice Orange

http://www.w3.org/2001/XMLSchema#string

Stefan Geider

http://www.w3.org/2001/XMLSchema#string

P2860

Safety of higher dosages of Viscum album L. in animals and humans--systematic review of immune changes and safety parameters

Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts

Hyperthermia as an immunotherapy strategy for cancer

Phase II clinical trial of intratumoral application of TG1042 (adenovirus-interferon-gamma) in patients with advanced cutaneous T-cell lymphomas and multilesional cutaneous B-cell lymphomas.

Cutaneous immunocytoma: a clinical, histologic, and phenotypic study of 11 cases.

Fever in Cancer Treatment: Coley's Therapy and Epidemiologic Observations

WHO-EORTC classification for cutaneous lymphomas.

Dietary mistletoe lectin supplementation and reduced growth of a murine non-Hodgkin lymphoma.

European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.

Lymphoma risks in populations with altered immunity--a search for mechanism.

P304

18-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7453/GAHMJ.2012.1.1.006

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258925322

http://www.w3.org/2001/XMLSchema#string

P698

24278797

http://www.w3.org/2001/XMLSchema#string

P932

3833476

http://www.w3.org/2001/XMLSchema#string